The universal survival benefit with kidney transplant over dialysis does not apply to older and high-risk patients receiving ...

Significant reductions in proteinuria, estimated glomerular filtration rate stability of the C3/C3b inhibitor were also ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

The patient arriving for a primary care visit had diabetes and a history of hypertension. He was 97 years old. But now, “his ...

Low-dose methotrexate for 1 year does not reduce knee pain or effusion-synovitis in patients with inflammatory knee ...

Significant support and follow-up’ may be necessary for older patients to implement their care plans, according to a ...

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

New research shows flood exposure increases hospitalisation risks for up to 7 months, affecting cardiovascular, metabolic, ...

Obefazimod shows efficacy and favourable safety in patients with moderate to severely active ulcerative colitis in a 96-week ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...